Chemotherapy Drugs 101: Vinca alkaloids

Chemotherapy.

The word instills terror, invokes images of hair loss, weakness, sickness. It can be an extraordinarily trying time, for patients and their caregivers. The literally hundreds of different drugs used in chemotherapy treatment can be daunting. In order to try and remove some of the terror and mystery of chemo, I'm going to use this blog to take an occasional look at the various groups of drugs used in chemo—their names, what they are, and what they do—to cancer cells and to our bodies.

In this entry I'll be looking at a couple of the so-called vinca alkaloids. Unlike the anti-metabolites, which work during the S phase of the cell cycle, vinca alkaloids go to work during the M phase of the cell cycle, or the mitotic phase. In this phase, a cell divides into two genetically identical cells. Mitotic inhibitors like vinca alkaloids disrupt this division by suppressing the protein tubulin, which a cell requires in order to divide.

Unfortunately, like other chemotherapy drugs that disrupt the growth of cells, vinca alkaloids are indiscriminate and can affect healthy cells as well. Such is the trade-off in chemotherapy treatments.

The following are some of the primary vinca alkaloids used in lymphomas such as Hodgkin's Lymphoma and non-Hodgkin's Lymphoma. Click on the drug to be taken to the American Cancer Society's patient page for that drug, which contains general information as well as potential side effects.

Vincristine (marketed as Oncovin, Vincasar PFS, Vincrex, vincristine sulfate, and VCR). Vincristine is part of the CHOP regimen, as well as MOPP, COPP, and BEACOPP regimens.

Vinblastine (marketed as Velban, Velbe, Velsar, vincaleukoblastine (VLB), vinblastine sulfate). Vinblastine Is a chemical analogue of vincristine and is used in the ABVD regimen for treating Hodgkin's lymphoma.

Vindesine (marketed as Eldisine). Vindesine is used to treat leukemias, lymphomas and other cancers.

Note: The World Health Organization's Anatomical Therapeutic Chemical Classification System (ATC) classifies vinca alkaloids as L01CA.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap